| |
PBC n = 62 (%)
|
AIC n = 17(%)
|
BD n = 100
|
CD n = 18
|
|---|
|
IgA-AGA
|
12(19)*
|
6 (35)*
|
1
|
18
|
|
IgG-AGA
|
3(5)
|
-
|
2
|
16
|
|
Any AGA
|
13 (21)*
|
6 (35)*
|
3
|
18
|
|
Both AGAs
|
2(3)
|
-
|
1
|
16
|
|
IgA-ARA
|
-
|
-
|
-
|
18
|
|
IgA-EMA
|
-
|
-
|
-
|
18
|
|
IgA-tTG
|
6(10)*
|
3(18)*
|
-
|
18
|
|
IgA-tTG and AGAs
|
2(3)
|
2 (12)*
|
-
|
18
|
- n = number of patients; * = where p less than 0.05, PBC = primary biliary cirrhosis; AIC = autoimmune cholangitis; CD = coeliac disease; BD = blood donors; IgA-AGA = anti-gliadin antibodies, IgA class; IgG-AGA = anti-gliadin antibodies, IgG class; AGAs = anti-gliadin antibodies; IgA-ARA = IgA class anti-reticulin antibodies, RI type; IgA-EMA = anti-endomysial antibodies, IgA class; IgA-tTG = antibodies to tissue transglutaminase, IgA class
